Brimonidine gel (Mirvaso▼): risk of exacerbation of rosacea
Some patients may have exacerbation or rebound symptoms of rosacea.
Show your support for reporting suspected adverse drug reactions
We are running a social media campaign to promote the reporting of suspected adverse drug reactions to the Yellow Card Scheme in support of an awareness week from 7 to 11 November 2016.
Letters sent to healthcare professionals in October 2016
A summary of recent safety letters sent to relevant healthcare professionals